Sun Pharma shares down 5% post Q4 results, brokerages divided
Sun Pharma clocked a 19% dip in consolidated net profit for the quarter ended March 2025 at ₹2,149 crore compared to ₹2,654 crore in the year-ago quarter Read More | Source: The Hindu Business Line